145 related articles for article (PubMed ID: 31374056)
1. Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using 18F-FDG PET.
Yoon JK; Byun C; Jo KS; Hur H; Lee KM; Lim SK; Lee D; Lee SJ; An YS; Han SU
Medicine (Baltimore); 2019 Aug; 98(31):e16690. PubMed ID: 31374056
[TBL] [Abstract][Full Text] [Related]
2. Primary Tumor ¹⁸F-FDG Avidity Affects the Performance of ¹⁸F-FDG PET/CT for Detecting Gastric Cancer Recurrence.
Kim SJ; Cho YS; Moon SH; Bae JM; Kim S; Choe YS; Kim BT; Lee KH
J Nucl Med; 2016 Apr; 57(4):544-50. PubMed ID: 26678615
[TBL] [Abstract][Full Text] [Related]
3. Improving patient selection for 18F-FDG PET scanning in the staging of gastric cancer.
Kaneko Y; Murray WK; Link E; Hicks RJ; Duong C
J Nucl Med; 2015 Apr; 56(4):523-9. PubMed ID: 25745094
[TBL] [Abstract][Full Text] [Related]
4. Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?
Perlaza P; Ortín J; Pagès M; Buxó E; Fernández-Esparrach G; Colletti PM; Rubello D; Mayoral M; Sánchez N; Ruiz C; Ginés A; Fuster D
Clin Nucl Med; 2018 Jun; 43(6):402-410. PubMed ID: 29485442
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.
Mochiki E; Kuwano H; Katoh H; Asao T; Oriuchi N; Endo K
World J Surg; 2004 Mar; 28(3):247-53. PubMed ID: 14961197
[TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of F-18 FDG PET in lymphoepithelioma-like gastric carcinoma.
Park S; Lee D; Lee KM; Han SU; Lee JH; Lee SJ; An YS; Yoon JK
Eur J Radiol; 2017 Sep; 94():160-166. PubMed ID: 28712702
[TBL] [Abstract][Full Text] [Related]
7. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
Chen J; Cheong JH; Yun MJ; Kim J; Lim JS; Hyung WJ; Noh SH
Cancer; 2005 Jun; 103(11):2383-90. PubMed ID: 15856477
[TBL] [Abstract][Full Text] [Related]
8. The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer.
Oh HH; Lee SE; Choi IS; Choi WJ; Yoon DS; Min HS; Ra YM; Moon JI; Kang YH
J Surg Oncol; 2011 Oct; 104(5):530-3. PubMed ID: 21618250
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT to predict the curability of endoscopic resection for early gastric cancer.
Chung HW; Kim JH; Sung IK; Lee SY; Park HS; Shim CS; Bang HY; So Y; Lee EJ
J Cancer Res Clin Oncol; 2019 Mar; 145(3):759-764. PubMed ID: 30603905
[TBL] [Abstract][Full Text] [Related]
10. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
Kawanaka Y; Kitajima K; Fukushima K; Mouri M; Doi H; Oshima T; Niwa H; Kaibe N; Sasako M; Tomita T; Miwa H; Hirota S
Eur J Radiol; 2016 May; 85(5):989-95. PubMed ID: 27130061
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer.
Song BI; Kim HW; Won KS; Ryu SW; Sohn SS; Kang YN
Medicine (Baltimore); 2015 Jul; 94(26):e1037. PubMed ID: 26131811
[TBL] [Abstract][Full Text] [Related]
12. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
[TBL] [Abstract][Full Text] [Related]
13. Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer.
Lee DH; Kim SH; Joo I; Hur BY; Han JK
Eur J Radiol; 2016 Jun; 85(6):1085-91. PubMed ID: 27161056
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M
Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670
[TBL] [Abstract][Full Text] [Related]
15. Routinely staging gastric cancer with
Findlay JM; Antonowicz S; Segaran A; El Kafsi J; Zhang A; Bradley KM; Gillies RS; Maynard ND; Middleton MR
Eur Radiol; 2019 May; 29(5):2490-2498. PubMed ID: 30643947
[TBL] [Abstract][Full Text] [Related]
16. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of preoperative FDG-PET for detection of gastric cancer.
Mukai K; Ishida Y; Okajima K; Isozaki H; Morimoto T; Nishiyama S
Gastric Cancer; 2006; 9(3):192-6. PubMed ID: 16952037
[TBL] [Abstract][Full Text] [Related]
18. Significance of CT attenuation and F-18 fluorodeoxyglucose uptake of visceral adipose tissue for predicting survival in gastric cancer patients after curative surgical resection.
Lee JW; Son MW; Chung IK; Cho YS; Lee MS; Lee SM
Gastric Cancer; 2020 Mar; 23(2):273-284. PubMed ID: 31485803
[TBL] [Abstract][Full Text] [Related]
19. Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer.
Sun G; Cheng C; Li X; Wang T; Yang J; Li D
Cancer Imaging; 2019 Mar; 19(1):18. PubMed ID: 30902116
[TBL] [Abstract][Full Text] [Related]
20. Impact of
Al-Ibraheem A; Hirmas N; Fanti S; Paez D; Abuhijla F; Al-Rimawi D; Al-Rasheed U; Abdeljalil R; Hawari F; Alrabi K; Mansour A
BMC Med Imaging; 2021 Mar; 21(1):49. PubMed ID: 33731050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
